Daewoong Indonesia History
Daewoong : 20 Years of Growth with Indonesia
2020s
2010s
2000s
Daewoong :
20 Years of Growth with Indonesia
Since 2005, Daewoong has been a key partner in Indonesia’s pharmaceutical and biopharmaceutical industry. From establishing the country’s first GMP biopharmaceutical plant to launching Indonesia’s first biosimilar, Daewoong has led innovation in Indonesian healthcare. Through scholarship programs, research institutes, and social contributions, Daewoong continues to nurture local talent and expand medical access. In 2024, we obtained GMP certification for stem cell production and launched the DF Korean Center in Bali, marking a new chapter of collaboration and innovation. Daewoong remains committed to advancing healthcare and growing together with Indonesia.
the 2020s,
Present
2024.10
DW-ITB Drug Delivery System Research Institute opened, joint research projects discovered
Opened DF Korean Center in Bali
2024.09
Daewoong Biologics obtains GMP certification for stem cell processing and production facility
2024.06
Signed MOU for primate research with IPB,securing competitiveness in preclinical research
2023
K-Aesthetic Clinic, ‘NULOOK’ opened NULOOK designated as the children's health management institution for the Flower of Hope Orphanage.
2022
Donation of  ‘foam dressing’ Easy Foam to earthquake victims (CGBio)

Started recruiting and nurturing excellent Indonesian talent
in the quality department (QA∙QC) at the Osong plant
2021
Master’s and Doctoral Credit Completion Scholarship Program
(Drug Delivery System) begins
2020
Launch of a scholarship program for outstanding Indonesian talent
the 2010s
2019
Health checkups for 1,000 Indonesian firefighters, spinal surgery for 100 people
2018
Established Bio Technology Research Center in University Indonesia
Conduct biopharmaceutical stability analysis and bio talent development
2017
Production of Indonesia’s first biosimilar ‘Epodion’Export of bulk API (EPO Epodion) produced by Daewoong Infion
2015
Daewoong Infion obtains GMP certification through PIC/sand on-site inspection by the Korean Ministry of Food and Drug Safety
2012
The establishment of the joint venture Daewoong Infion marks the beginning of mutual growth in earnest

Construction of Indonesia's first biopharmaceutical factory meeting cGMP standards
the 2000s
2009
Launch of a scholarship program for outstanding Indonesian talent
2005
DPCI Established in Jakarta as the Indonesian Branch